Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

@article{Seeff2001LongtermMA,
  title={Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.},
  author={Leonard B. Seeff and F. Blaine Hollinger and Harvey J. Alter and Elizabeth C. Wright and Courtney M Cain and Zelma J Buskell and Kamal G. Ishak and Frank L. Iber and Doris H. Toro and Arun Samanta and Ronald L Koretz and Robert P. Perrillo and Zachary D. Goodman and Robert G. Knodell and Gary Gitnick and Timothy R. Morgan and Eugene R Schiff and Stephanie Lasky and Christopher Stevens and R Z Vlahcevic and Elizabeth H. Weinshel and Tawesak Tanwandee and Hsiang Ju Lin and Laura Barbosa},
  journal={Hepatology},
  year={2001},
  volume={33 2},
  pages={455-63}
}
Persons with non-A, non-B hepatitis (cases) identified in 5 transfusion studies in the early 1970s have been followed ever since and compared for outcome with matched, transfused, non-hepatitis controls from the same studies. Previously, we reported no difference in all-cause mortality but slightly increased liver-related mortality between these cohorts after 18 years follow-up. We now present mortality and morbidity data after approximately 25 years of follow-up, restricted to the 3 studies… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 127 extracted citations

Similar Papers

Loading similar papers…